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Cardiac alternans is a high risk indicator for cardiac arrhythmias, stroke and
sudden cardiac death. The cardioactive peptide Urocortin 2 (Ucn2) exhibits
beneficial effects in normal and failing hearts, and elicits PKA-dependent pos-
itive inotropic and lusitropic effects in normal myocytes. Thus, we investigated
if Ucn2 protects against pacing-induced alternans and elucidated the underlying
mechanism.
Experiments were performed on single rabbit atrial and ventricular myocytes
from normal and failing hearts. Chronic heart failure was induced by combined
pressure and volume overload. Ca alternans was induced by incrementally
increasing the pacing frequency until stable Ca alternans occurred at room tem-
perature. Global Ca transients were measured with the fluorescent Ca indicators
Fluo-4 or Indo-1 and monitored simultaneously with mechanical alternans
(sarcomere length). In some experiments, cytosolic Ca alternans and intra-SR
Ca alternans were simultaneously recorded with the Ca indicators Rhod-2
and Fluo-5N, respectively.
The average alternans ratio (AR = 1-(small-amplitude/large-amplitude)) in
atrial myocytes was 0.79, and in normal and failing ventricular myocytes
the ARs were 0.69 and 0.64, respectively. Ucn2 (100 nM) completely abol-
ished Ca and mechanical alternans (within 2-3 min) in atrial and ventricular
myocytes from normal and failing hearts. An increased sarcoplasmic reticu-
lum (SR) Ca content, together with an enhanced SR Ca release flux, suggested
that Ucn2 normalized alternans through effects on SR Ca ATPase (SERCA).
Ucn2 increased significantly the level of cyclic adenosine monophosphate
(cAMP) in normal cells (~12-fold), and enhanced phosphorylation of phos-
pholamban (PLB) at Ser16 in normal myocytes (~10-fold) and to a lesser
extent (~5-fold) in failing myocytes. These data demonstrate that Ucn2
rescues alternans presumably via increased SERCA activity in atrial and
ventricular myocytes and thus protects normal and failing hearts from proar-
rhythmic alternans.
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NOS1AP gene (nitric oxide synthase 1-adaptor protein) is strongly associated
with abnormalities in the QT interval of the electrocardiogram and with
sudden cardiac death. To determine the role of NOS1AP in the physiology
of the cardiac myocyte, we assessed the impact of silencing NOS1AP, using
siRNA, on [Ca2þ]i transients in neonatal cardiomyocytes. In addition, we
examined the co-localization of NOS1AP with cardiac ion channels, and
finally, evaluated the expression of NOS1AP in a mouse model of dystrophic
cardiomyopathy.
Using siRNA, NOS1AP levels were reduced to ~30% of the control levels
(p<0.05). NOS1AP silencing in cardiac myocytes reduced significantly the
amplitude of electrically evoked calcium transients (p<0.05) and the degree
of S-nitrosylation of the cells (p<0.05). Using confocal microscopy, we eval-
uated NOS1AP subcellular location and interactions with other proteins by
co-localization analysis. NOS1AP showed a high degree of co-localization
with the L-type calcium channel and the inwardly rectifying potassium channel
Kir3.1, a low degree of co-localization with the ryanodine receptor (RyR2) and
alfa-sarcomeric actin and no co-localization with connexin 43, suggesting func-
tionally relevant interactions with the ion channels that regulate the action
potential duration.
Finally, using immunofluorescence and Western blotting, we observed
that in mice with dystrophic cardiomyopathy, NOS1AP was significantly up-
regulated (p<0.05).
These results suggest for a role of NOS1AP on cardiac arrhythmias, acting on
the L-type calcium channel, and potassium channels, probably through
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Duchenne muscular dystrophy (DMD) is caused by the absence of dystrophin
expression and is one of the most common genetic diseases of children world-
wide. Duchenne cardiomyopathy (D-CM) is observed in all patients suffering
from DMD as the disease progresses. Despite knowing the cause of DMD
and D-CM, there are no treatments which reverse its inevitable progression.
Periodic Acceleration (pGz) is a novel method that applies repetitive, sinusoi-
dal, head-to-foot motion to a horizontally positioned body to induce increased
pulsatile shear stress in fluid channels throughout the entire body. pGz increases
the expression of eNOS, and nNOS and other endothelial derived proteins. Ex-
periments were conducted in cardiomyocytes isolated from Wt and mdx mice
(3, 6, 9 and 12-mo), treated or not with pGz (one hour for 16 consecutive days).
Resting Ca2þ ([Ca2þ]r) and Naþ ([Naþ]r) were determined using Ca2þ and Naþ
selective microelectrodes. pGz did not modify [Ca2þ]r or [Naþ]r in cardiomyo-
cytes from Wt mice at any age (3, 6, 9 and 12-mo). In contrast, pGz restored
[Ca2þ]r and [Naþ]r to Wt levels in cardiomyocytes from 3, 6 and 9-mo mdx
mice and significantly reduced [Ca2þ]r and [Naþ]r in those from 12-mo old
mdx mice. To assess the [NO]i Wt and mdx cardiomyocytes isolated from
mice of 3, 6, 9 and 12-mo of age were loaded with 10mM DAF-FM DA
(Molecular Probes, OR, USA). pGz did not significantly modify DAF fluores-
cence in Wt cardiomyocytes at any age. In contrast, pGz reduced DAF-
Fluorescence in treated mdx cardiomyocytes at 3,6, 9 and 12 mo of age
compared to untreated mdx cardiomyocytes of the same age. Our results
suggest that pGz can be a drug free therapeutic approach to treat the cardiomy-
opathy observed in patients suffering from D-CM.
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Compelling evidence suggests that reduced sarcoplasmic reticulum (SR) Ca2þ
uptake via the SR Ca2þ ATPase (SERCA) is a major contributor to the devel-
opment of Ca2þ signaling abnormalities in heart failure, and equally important
as other known contributors to impaired Ca2þ handling.
Mathematical models of Ca2þ uptake via SERCA have been proposed,
including recent ‘state-model’ descriptions that represent distinct catalytic
states of the ATPase.
While these state models have answered important questions about the pump’s
dependence on Ca2þ, Mg2þ, and the free energy of ATP hydrolysis, to our
knowledge state-based models that account for SERCA’s molecular interaction
with the endogenous phospholamban inhibitor are less well-developed.
We thus propose a SERCA Ca2þ uptake model that is based on a sequence of
crystallographically-determined conformational states.
These distinct conformations have been shown to give rise to the cooperativity
of cytosolic Ca2þ binding, and the kinetics of which are altered by phos-
pholamban binding.
We apply the new SERCA model to a 3-dimensional model of Ca2þ signaling
in a realistic, confocal-microscopy derived cardiac ventricular myocyte, with
which we demonstrate the effects of altered Ca2þ cooperativity on the Ca2þ
transient.
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During every heartbeat, the Ca2þ that is released must be reabsorbed into the
sarcoplasmic reticulum (SR) sufficiently rapidly to allow the heart to relax
and refill. Taking an economic viewpoint, we hypothesized that the organism
would optimally balance the need to absorb Ca2þ sufficiently rapidly and the
metabolic cost of producing SR ATPases (SERCA2). To test this hypothesis
we simulated the release and uptake of Ca2þ with different reticulation topol-
ogies and fractional covering. We defined a cost function that includes the cost
of ATPase production, a penalty for not absorbing Ca2þ sufficiently rapidly,
and a penalty for insufficient Ca2þ binding to contractile proteins. We found
that the optimal SR fractional covering (where a value of 1 corresponds to
